Takeda Pharmaceutical Dividends and Buybacks
Dividend criteria checks 5/6
Takeda Pharmaceutical is a dividend paying company with a current yield of 4.69%.
Key information
4.7%
Dividend yield
0.03%
Buyback Yield
| Total Shareholder Yield | 4.7% |
| Future Dividend Yield | 5.0% |
| Dividend Growth | 3.9% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | US$1.286 |
| Payout ratio | 104% |
Recent dividend and buyback updates
Recent updates
Takeda Pharmaceuticals: An Interesting Option For Income Investors
Oct 07Takeda: Strong Growth Catalysts And Maturing Pipeline Continue To Limit Downside Risk
Jun 06Takeda Pharmaceutical Company: Attractive Stock But Needs To Grow Net Profits
Mar 03Takeda: Why I'm Staying Bearish On This Generic Drug Dividend Play
Oct 24Takeda: Innovative But Volatile, Fairly Priced For The Risk (Downgrade)
Aug 31Takeda: Upside Case Strengthening, Looking To 15x Earnings
Jun 21Stability and Growth of Payments
Fetching dividends data
Stable Dividend: TAK's dividends per share have been stable in the past 10 years.
Growing Dividend: TAK's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Takeda Pharmaceutical Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (TAK) | 4.7% |
| Market Bottom 25% (US) | 1.4% |
| Market Top 25% (US) | 4.2% |
| Industry Average (Pharmaceuticals) | 2.4% |
| Analyst forecast (TAK) (up to 3 years) | 5.0% |
Notable Dividend: TAK's dividend (4.69%) is higher than the bottom 25% of dividend payers in the US market (1.35%).
High Dividend: TAK's dividend (4.69%) is in the top 25% of dividend payers in the US market (4.19%)
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (104.1%), TAK's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (57.9%), TAK's dividend payments are covered by cash flows.